Alexander A. Firsov

1.7k total citations
73 papers, 1.4k citations indexed

About

Alexander A. Firsov is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Alexander A. Firsov has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pharmacology, 51 papers in Molecular Medicine and 27 papers in Infectious Diseases. Recurrent topics in Alexander A. Firsov's work include Antibiotics Pharmacokinetics and Efficacy (66 papers), Antibiotic Resistance in Bacteria (51 papers) and Antimicrobial Resistance in Staphylococcus (26 papers). Alexander A. Firsov is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (66 papers), Antibiotic Resistance in Bacteria (51 papers) and Antimicrobial Resistance in Staphylococcus (26 papers). Alexander A. Firsov collaborates with scholars based in Russia, United States and Czechia. Alexander A. Firsov's co-authors include Stephen H. Zinner, Sergey N. Vostrov, Yury A. Portnoy, Irene Yu Lubenko, Elena N. Strukova, Karl Drlica, Giuseppe Cornaglia, Deborah Gilbert, O. V. Kononenko and Р. Г. Василов and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Alexander A. Firsov

73 papers receiving 1.3k citations

Peers

Countries citing papers authored by Alexander A. Firsov

Since Specialization

Citations

This map shows the geographic impact of Alexander A. Firsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander A. Firsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander A. Firsov more than expected).

Fields of papers citing papers by Alexander A. Firsov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander A. Firsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander A. Firsov. The network helps show where Alexander A. Firsov may publish in the future.

Co-authorship network of co-authors of Alexander A. Firsov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander A. Firsov. A scholar is included among the top collaborators of Alexander A. Firsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander A. Firsov. Alexander A. Firsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting the antistaphylococcal effects of daptomycin–rifampicin combinations in an in vitro dynamic model 2019 ·The Journal of Antibiotics ·(unknown), Elena N. Strukova, Yury A. Portnoy, Stephen H. Zinner, Alexander A. Firsov	5
2	Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin 2018 ·International Journal of Antimicrobial Agents ·Stephen H. Zinner, (unknown), Elena N. Strukova, Yury A. Portnoy, Alexander A. Firsov	10
3	Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model 2017 ·Journal of Antimicrobial Chemotherapy ·Alexander A. Firsov, (unknown), Elena N. Strukova, (unknown), Yury A. Portnoy, (unknown), (unknown), (unknown), Mikhail V. Edelstein, Stephen H. Zinner	17
4	Synthesis and Antibacterial Activity of Quaternary Ammonium 4-Deoxypyridoxine Derivatives 2016 ·BioMed Research International ·Nikita V. Shtyrlin, (unknown), (unknown), Airat R. Kayumov, Oksana V. Bondar, Elena P. Mirchink, Elena B. Isakova, Alexander A. Firsov, Konstantin V. Balakin, Yurii G. Shtyrlin	24
5	Predictors of bacterial resistance usingin vitrodynamic models: area under the concentration–time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration 2015 ·Journal of Antimicrobial Chemotherapy ·Elena N. Strukova, Yury A. Portnoy, Stephen H. Zinner, Alexander A. Firsov	15
6	Predicting bacterial resistance using the time inside the mutant selection window: Possibilities and limitations 2014 ·International Journal of Antimicrobial Agents ·Alexander A. Firsov, Yury A. Portnoy, Elena N. Strukova, (unknown), Stephen H. Zinner	19
7	Bacterial Resistance Studies Using In Vitro Dynamic Models: the Predictive Power of the Mutant Prevention and Minimum Inhibitory Antibiotic Concentrations 2013 ·Antimicrobial Agents and Chemotherapy ·Alexander A. Firsov, Elena N. Strukova, (unknown), Yury A. Portnoy, Varvara K. Kozyreva, Mikhail V. Edelstein, (unknown), (unknown), Stephen H. Zinner	30
8	Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model 2012 ·Journal of Antimicrobial Chemotherapy ·Stephen H. Zinner, Deborah Gilbert, K.L. Greer, Yury A. Portnoy, Alexander A. Firsov	15
9	The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models 2009 ·Journal of Antimicrobial Chemotherapy ·(unknown), Sergey N. Vostrov, Elena N. Strukova, (unknown), (unknown), Yury A. Portnoy, Stephen H. Zinner, Alexander A. Firsov	11
10	Concentration–response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model 2007 ·International Journal of Antimicrobial Agents ·(unknown), Irene Yu Lubenko, Yury A. Portnoy, Stephen H. Zinner, Alexander A. Firsov	5
11	Antibiotic pharmacodynamics and bacterial resistance: Usefulness of in vitro models 2007 ·Current Infectious Disease Reports ·Stephen H. Zinner, Alexander A. Firsov	1
12	Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model 2006 ·Journal of Antimicrobial Chemotherapy ·Alexander A. Firsov, (unknown), Irene Yu Lubenko, Sergey N. Vostrov, Yury A. Portnoy, Stephen H. Zinner	75
13	Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model 2004 ·International Journal of Antimicrobial Agents ·Stephen H. Zinner, Sergey N. Vostrov, (unknown), Irene Yu Lubenko, Yury A. Portnoy, Alexander A. Firsov	11
14	ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model 2004 ·Journal of Antimicrobial Chemotherapy ·Alexander A. Firsov	37
15	Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination 2004 ·International Journal of Antimicrobial Agents ·Alexander A. Firsov, Sergey N. Vostrov, Irene Yu Lubenko, Yury A. Portnoy, Stephen H. Zinner	31
16	Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination 2003 ·International Journal of Antimicrobial Agents ·Alexander A. Firsov	17
17	Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils 2002 ·Journal of Antimicrobial Chemotherapy ·Alexander A. Firsov	11
18	AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin 2002 ·Journal of Antimicrobial Chemotherapy ·Alexander A. Firsov	20
19	Use of modeling techniques to aid in antibiotic selection 2001 ·Current Infectious Disease Reports ·Alexander A. Firsov, Stephen H. Zinner	12
20	Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model 1999 ·Journal of Antimicrobial Chemotherapy ·Alexander A. Firsov, Р. Г. Василов, Sergey N. Vostrov, O. V. Kononenko, Irene Yu Lubenko, Stephen H. Zinner	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact